In addition to the regular publications, BioPharma Dealmakers also present a series of Nature.com Webcasts that are designed to inform and educate the community about promising new science from leading companies in the field of interest. The program is developed and moderated by a Nature Publishing Group Editor, ensuring quality and involves a panel of high-quality experts that present their science and partake in a roundtable or Q&A summary session.

*Upcoming webcast*

New innovations in drug delivery technology

Applicable to all diseases, it is no surprise that the market for drug delivery technologies continues to expand as innovators explore new approaches to deliver biologics, as well as cell and gene therapies.

In this webcast we will bring a number of these innovators together to present their range of diverse technologies and explain their applications in diseases such as oncology, CNS diseases and women’s health. Technologies covered within the webcast will include, digitally controlled needle-free devices, sustained and controlled transdermal delivery technology, fiber-based technology for implantable devices, targeted penetration matrix technology for non-invasive delivery and location-specific nano machines for chemotherapy payload delivery.

The webcast will conclude with a live roundtable discussion and a Q&A session with the speakers so that you the audience can put your own questions to them.

Register now

Date: March 29, 2017
Time: 8am PDT / 11am EDT / 4pm BST / 5pm CEST
Price: FREE

All sponsor logos

Past webcasts

Advances in precision medicine and genomic sequencing

Next-generation sequencing platforms are opening up new opportunities in precision medicine by dramatically reducing the cost and time to access large volumes of genomic data.
This webcast will highlight innovative technologies being developed by companies in the field, and how they are laying the groundwork for novel therapeutics and diagnostics in areas such as oncology and rare diseases. The topics will include advanced bioinformatics and next-generation sequencing for pathogen detection, nanosensor technology for genome sequencing and healthcare diagnostics, molecular indexing technology for digital detection of single cells and cloud-based accelerated genomics analysis.

The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to hear the views of the speakers and to put your own questions to them.

Watch on-demand now

4 Logos


Innovating for ophthalmic diseases

The increased need for more effective treatments for diseases of the eye such as glaucoma, macular degeneration and dry eye, coupled with technological advances in areas such as regenerative medicine, are providing exciting opportunities for companies to develop new eye care products.

This webcast will explore some of the latest advances in the ophthalmic field through discussion with representatives from companies developing a range of innovative therapies for eye disorders, including the use of iPS cells, eye drops to deliver small-molecule drugs and complement inhibition.

The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to participate and put your own questions to the speakers.

Watch on-demand now

Pain targeting mechanisms

The demand for new therapeutic strategies for pain is high because established drugs have major limitations, including lack of efficacy for conditions such as neuropathic pain and the potential for abuse for opioids. In this webcast, several companies that are working to target unmet needs in pain management will present their developments, which include analgesics with novel mechanisms of action, opioids with reduced potential for abuse and medical devices.

The webcast will also include a roundtable discussion and a Q&A section to allow you to hear direct expert opinions from the speakers and contribute your own thoughts.

Watch on-demand now



Options for tackling antibiotic resistance

The growing threat of antibiotic resistance has accelerated regulatory, policy and funding initiatives over recent years, leading to a wave of new innovations in the area. In this webcast, experts from several companies in the field return to examine what is being done to tackle the impending antibiotic resistance crisis. A range of approaches include antibiotic-resistance breakers, macrocycles and other antibiotic classes for infections caused by key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus are presented by the companies.

The webcast will also include a new and extended roundtable discussion and a Q&A section to allow you to participate and ask the speakers how they intend to tackle the emerging antibiotic resistance crisis.

Watch on-demand now

Combating antibiotic resistance

With antibiotic resistance increasingly being acknowledged as a major public health threat, regulatory and policy initiatives and a growth in funding are now catalysing the revitalization of R&D in the area. In this webcast, experts from several companies in the field will examine what is being done to combat antibiotic resistance, covering approaches including antibiotic-resistance breakers, macrocycles and other antibiotic classes for infections caused by key pathogens such as Pseudomonas aeruginosa andStaphylococcus aureus.

The webcast also includes a roundtable discussion and a Q&A section to allow you to participate and contribute your own thoughts on efforts to tackle the emerging antibiotic resistance crisis.

Watch on-demand now


Developing next-generation antibody technologies

Monoclonal antibodies make up almost half of the list of the top 10 biggest-selling drugs. A wave of next-generation products — including antibody–drug conjugates (ADCs) and bispecific antibodies — promise to broaden the applicability of antibody technology further.

This webcast, featuring experts from two companies in the field, will highlight the potential of next-generation antibody technologies. By tuning in you will learn about established approaches to improve antibody production and enhance the therapeutic index of ADCs

Watch on-demand now





Innovations in Regenerative Medicine and Curative Biologics

Undoubtedly one of the most exciting fields in healthcare, regenerative therapeutics are getting closer and closer to changing the face of medicine. Evolving technologies such as gene therapy, tissue engineering and stem cells are gaining increasing attention of big pharma, following successful clinical trial results driven by advances in addressing long-standing technical challenges. For example, several million-dollar partnerships to develop gene therapies for haemophilia, ophthalmic and for severe central nervous system disorders were signed by the industry’s top pharma companies over the last year.

Furthermore, genome editing technologies such as CRISPR and zinc-finger nucleases have opened up new strategies for therapeutic intervention, leading to a wave of funding into emerging companies in the area.

This webcast explores some of the challenges and opportunities of cutting edge technologies in regenerative medicine and curative biologics.
Watch on-demand now


Advances in Cancer Immunotherapy

Since the introduction of antibodies to the treatment of cancer, immunotherapies and targeted therapies have had a dramatic effect on the field. The earliest immunotherapy introduced for the treatment of cancer was humanized-murine antibodies directed against single-cell surface markers present on lymphoma and leukemia cells. While this marked a great advance in the treatment of cancer, innovations have come a long way since then and have helped improve upon nearly every aspect of the discovery, engineering and manufacture of immunotherapies for the treatment of cancer.
This webcast explores some of the challenges and opportunities of technologies at the cutting edge of cancer immunotherapy.
Watch on-demand now